ArticleJournal of microbiology (Seoul, Korea)2022

The efficacy of a 2,4-diaminoquinazoline compound as an intranasal vaccine adjuvant to protect against influenza A virus infection in vivo.

Kyungseob Noh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.